Skip to content
Altius – Lifestyle
Author:
Watson’s
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
August 19, 2026
Eikon Therapeutics Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
August 17, 2026
Eikon Therapeutics Announces Availability of Six Abstracts for Presentation at the 2026 Annual Meeting of the American Society of Clinical Oncology
May 22, 2026
Watson’s Accelerates Strategic Growth with Acquisition of Viridien Patio + Fireplace, Strengthening Southern U.S. Presence
May 18, 2026